Upexi, Inc.

NasdaqCM UPXI

Upexi, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2024

Upexi, Inc. EBITDA Margin is NA for the Trailing 12 Months (TTM) ending September 30, 2024. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Upexi, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.42%, a 103.09% change year over year.
Upexi, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -13.49%, a -246.55% change year over year.
Upexi, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 9.20%, a 119.84% change year over year.
Upexi, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -46.38%.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

NasdaqCM: UPXI

Upexi, Inc.

CEO	Mr. Allan J. Marshall
IPO Date	June 24, 2021
Location	United States
Headquarters	17129 US Hwy 19 N
Employees	95
Sector	Consumer Discretionary
Industries Cosmetics Pharmaceuticals

Description

Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.

Key trends

Past 5 years